A detailed history of D. E. Shaw & Co., Inc. transactions in Dexcom Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 2,429,523 shares of DXCM stock, worth $177 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,429,523
Holding current value
$177 Million
% of portfolio
0.15%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $153 Million - $278 Million
2,393,783 Added 6697.77%
2,429,523 $163 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $54.6 Million - $69.6 Million
-495,211 Reduced 93.27%
35,740 $4.05 Million
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $46.2 Million - $56.7 Million
404,440 Added 319.69%
530,951 $73.6 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $2.69 Million - $4.42 Million
-35,617 Reduced 21.97%
126,511 $15.7 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $10.4 Million - $16.6 Million
-120,448 Reduced 42.62%
162,128 $15.1 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $14 Million - $16.3 Million
124,523 Added 78.79%
282,576 $36.3 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $10.2 Million - $12.1 Million
98,408 Added 164.99%
158,053 $18.4 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $4.75 Million - $6.86 Million
55,884 Added 1485.88%
59,645 $6.75 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $7,864 - $9,700
103 Added 2.82%
3,761 $303,000
Q2 2022

Aug 15, 2022

SELL
$67.99 - $132.89 $230,894 - $451,294
-3,396 Reduced 48.14%
3,658 $273,000
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $908,624 - $1.26 Million
-9,658 Reduced 57.79%
7,054 $3.61 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $4.29 Million - $5.37 Million
-33,006 Reduced 66.39%
16,712 $8.97 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $1.85 Million - $2.48 Million
17,354 Added 53.62%
49,718 $27.2 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $740,815 - $987,235
9,147 Added 39.4%
32,364 $13.8 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $1.29 Million - $1.6 Million
15,257 Added 191.67%
23,217 $8.34 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $3.46 Million - $4.64 Million
-44,380 Reduced 84.79%
7,960 $2.94 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $3.51 Million - $4.16 Million
36,797 Added 236.74%
52,340 $21.6 Million
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $37.1 Million - $62.4 Million
-592,360 Reduced 97.44%
15,543 $6.3 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $12.8 Million - $20.2 Million
266,872 Added 78.25%
607,903 $164 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $12.1 Million - $18.9 Million
330,549 Added 3153.49%
341,031 $74.6 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $3.15 Million - $3.88 Million
-88,525 Reduced 89.41%
10,482 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $12.2 Million - $17.1 Million
-438,751 Reduced 81.59%
99,007 $14.8 Million
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $3.96 Million - $5.39 Million
-141,124 Reduced 20.79%
537,758 $64 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $9.51 Million - $13.2 Million
352,345 Added 107.9%
678,882 $81.3 Million
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $2.48 Million - $3.91 Million
106,377 Added 48.32%
326,537 $46.7 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $3.86 Million - $5.55 Million
220,160 New
220,160 $20.9 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.